Literature DB >> 25257311

The RAS and YAP1 dance, who is leading?

Vincenzo Corbo1, Mariano Ponz-Sarvise1, David A Tuveson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25257311      PMCID: PMC4283400          DOI: 10.15252/embj.201490014

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  10 in total

1.  A genetic screen in Drosophila for metastatic behavior.

Authors:  Raymond A Pagliarini; Tian Xu
Journal:  Science       Date:  2003-10-09       Impact factor: 47.728

2.  Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.

Authors:  Avnish Kapoor; Wantong Yao; Haoqiang Ying; Sujun Hua; Alison Liewen; Qiuyun Wang; Yi Zhong; Chang-Jiun Wu; Anguraj Sadanandam; Baoli Hu; Qing Chang; Gerald C Chu; Ramsey Al-Khalil; Shan Jiang; Hongai Xia; Eliot Fletcher-Sananikone; Carol Lim; Gillian I Horwitz; Andrea Viale; Piergiorgio Pettazzoni; Nora Sanchez; Huamin Wang; Alexei Protopopov; Jianhua Zhang; Timothy Heffernan; Randy L Johnson; Lynda Chin; Y Alan Wang; Giulio Draetta; Ronald A DePinho
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

3.  KRAS and YAP1 converge to regulate EMT and tumor survival.

Authors:  Diane D Shao; Wen Xue; Elsa B Krall; Arjun Bhutkar; Federica Piccioni; Xiaoxing Wang; Anna C Schinzel; Sabina Sood; Joseph Rosenbluh; Jong W Kim; Yaara Zwang; Thomas M Roberts; David E Root; Tyler Jacks; William C Hahn
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

4.  Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

Authors:  Stefano Piccolo; Michelangelo Cordenonsi; Sirio Dupont
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

Review 5.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

6.  Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Authors:  Weiying Zhang; Nivedita Nandakumar; Yuhao Shi; Mark Manzano; Alias Smith; Garrett Graham; Swati Gupta; Eveline E Vietsch; Sean Z Laughlin; Mandheer Wadhwa; Mahandranauth Chetram; Mrinmayi Joshi; Fen Wang; Bhaskar Kallakury; Jeffrey Toretsky; Anton Wellstein; Chunling Yi
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

7.  Viral small T oncoproteins transform cells by alleviating hippo-pathway-mediated inhibition of the YAP proto-oncogene.

Authors:  Hung Thanh Nguyen; Xin Hong; Sam Tan; Qingfeng Chen; Lifang Chan; Marc Fivaz; Stephen M Cohen; P Mathijs Voorhoeve
Journal:  Cell Rep       Date:  2014-07-31       Impact factor: 9.423

Review 8.  Negative feedback and adaptive resistance to the targeted therapy of cancer.

Authors:  Sarat Chandarlapaty
Journal:  Cancer Discov       Date:  2012-03-22       Impact factor: 39.397

9.  Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover.

Authors:  Xin Hong; Hung Thanh Nguyen; Qingfeng Chen; Rui Zhang; Zandra Hagman; P Mathijs Voorhoeve; Stephen M Cohen
Journal:  EMBO J       Date:  2014-09-01       Impact factor: 11.598

10.  YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.

Authors:  Jianmin Zhang; Jun-Yuan Ji; Min Yu; Michael Overholtzer; Gromoslaw A Smolen; Rebecca Wang; Joan S Brugge; Nicholas J Dyson; Daniel A Haber
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

  10 in total
  3 in total

Review 1.  Cell density regulates cancer metastasis via the Hippo pathway.

Authors:  Ghada M Sharif; Anton Wellstein
Journal:  Future Oncol       Date:  2015-11-12       Impact factor: 3.404

Review 2.  A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.

Authors:  Michael D Deel; Jenny J Li; Lisa E S Crose; Corinne M Linardic
Journal:  Front Oncol       Date:  2015-09-02       Impact factor: 6.244

Review 3.  EMT and Treatment Resistance in Pancreatic Cancer.

Authors:  Nicola Gaianigo; Davide Melisi; Carmine Carbone
Journal:  Cancers (Basel)       Date:  2017-09-12       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.